Agenda & Registration

register

21st ANNUAL ONCOLOGY RESEARCH & EDUCATION DAY

Best Western Plus Lamplighter Inn & Conference Centre
Crystal Ballroom, Regency Room, Chelsea Room & Atrium
591 Wellington Road, London

Thursday June 12, 2025 - 8:30AM to 5:00PM

Download Agenda as a PDF here (to be updated after May 12)
Download Conference Booklet here (to be updated after May 12)

REGISTER HERE



AGENDA

Overall Learning Objectives:

By the end of this program, participants will be able to:

1.To review contributions from different oncology disciplines, including medical oncology, radiation oncology, surgery, and medical biophysics, to a comprehensive cancer treatment approach; 2.Discuss and assess cutting-edge research in oncology, including novel methodologies for studying cancer at the cellular level and the implications for treatment resistance and patient care; 3.Appraise research findings and demonstrate how collaboration bridge clinical and basic science research in oncology.

7:45

Registration and Breakfast - Atrium

Please register and enjoy a light breakfast while networking with colleagues

8:30

Welcome and Opening Remarks - Crystal Ballroom

Daniel Breadner MD. FRCPC. and Saman Maleki PhD. - Conference Co-Chairs

Michael Ott MD. FRCSC. - Chair, Department of Oncology and Physician Executive Oncology LHSC

Kirk Baines - Philanthropist & Founder of the Baines Centre for Translational Cancer Research

9:00-10:00

Morning Oral Presentation - Crystal Ballroom

Judges:

Alison Allan PhD - VP, Western Research, Western University

Diwakar Davar MD - Clinical Director, Melanoma and Skin Cancer Program, UPMC Hillman Cancer Centre

Lisa Porter PhD - VP, Research and Scientific Director, St. Joseph's Health Care London

9:00 1.
9:15 2.
9:30 3.
9:45 4.
10:00-11:30

Poster Viewing and Judging (Odd Numbers) - Regency and Chelsea Conference Rooms

Please enjoy refreshments and light snack - Atrium

11:30-12:30

Keynote Lecture - Crystal Ballroom

"Uncovering metagenomic signatures of response, resistance and irAE development in ICI treated melanoma."

Diwakar Davar, MD. MS. 

Objectives:1.Understanding metagenomic signatures of response, resistance and irAE development in ICI treated melanoma, 2. Understanding that metagenomic signatures are ICI-regimen specific, 3. Using AI and ML to more accurately identify ICI-responders.

12:30-1:30

Lunch - Crystal Ballroom & Atrium

1:30-2:30

Afternoon Oral Presentations - Crystal Ballroom

Judges: Alison Allan PhD, Diwarkar Davar MD and Lisa Porter PhD

Crystal Ballroom

1:30

5.

1:45 6.
2:00 7.
2:15 8.
2:30-3:00

Panel Discussion - Enhancing Translational Research in London: Building Bridges Between Science and Medicine

Moderator: Saman Maleki PhD

Panelists:

  • Daniel Breadner MD - Medical Oncologist and Clinician Researcher
  • Diwakar Davar MD - Hematologist, Medical Oncologist and Clinician Researcher
  • Nicole Dearing - Patient Partner
  • Sarah Mattonen PhD - Imaging Scientist
  • Anthony Nichols MD PhD - Surgeon and Clinician Researcher
  • David Palma MD PhD - Radiation Oncologist and Clinician Researche

Crystal Ballroom 

3:00-4:30

Poster Viewing and Judging (Even Numbers) - Regency and Chelsea Conference Rooms

Please enjoy refreshments and light snack - Atrium

4:30

Presentation of Awards - Crystal Ballroom

Michael Ott - Department of Oncology, Academic Excellence Awards (5)

Morgan Black - Denise Power Cancer Research Staff Award of Excellence (1)

Daniel Breadner and Saman Maleki - Oral (2) and Poster Presentation Awards (10)

5:00

Concluding Remarks and Adjournment 

Daniel Breadner and Saman Maleki